Market Scenario

Vasectomy is permanent male sterilization surgery, which involves the male vas deferens being severed to prevent sperm from entering into the urethra and thus preventing fertilization. Vasectomy is performed by several methods such as open or conventional vasectomy, no-scalpel techniques or minimally invasive technique. Vasectomy is a permanent procedure as a reversal is costly and often does not restore the male's fertility due to low sperm count or sperm motility. Vasectomy is a simple surgical procedure, which takes less than thirty minutes and no hospital stay.  Most vasectomy patients can resume their sexual behavior within a week with little or no discomfort. Vasectomy may in some cases cause sperm granulomas due to the entry of the sperm into the scrotum and vasitis nodosa, which is a benign proliferation of the ductular epithelium. Vasectomy in about 60%-70% of cases causes anti-sperm antibodies.

Browse for Sample Copy @ https://www.marketresearchfuture.com/sample_request/4703 

Vasectomy is the most effective permanent contraception for men and has more positive outlook such as more cost-effective, less invasive, and has a much lower risk of postoperative complications. Almost 90% of men had reported satisfaction with vasectomy especially when both people in the relationship agreed on the procedure. Despite medical advances and the demonstration of the superiority of vasectomy, female sterilization is the most widely used method worldwide, with approx. 250 million tubectomy surgeries compared to a pitiful of approximately 30 million vasectomies.

The market drivers for global vasectomy market are rising demand due to growing population, increasing male-female equality, side effects of female contraception such as risk of cancer, hormonal disturbances, osteoporosis, rise in body weight etc., high safety profile of vasectomy and its simplicity over tubectomy, low cost of the surgical procedure and lack of hospitalization and others. The market restraints are the complications such as the risk of bleeding, infections, etc., lack of awareness, issues of male supremacy coupled with the non-reversible nature of vasectomy, social taboo, especially, in the developing regions and others.

The global vasectomy market is expected to reach USD 24.0 billion at a CAGR of ~ 7.1 % during the by the end of forecast period 2017-2023.

Key Players in the Global Vasectomy Market

Some of the key players profiled in the report are Pfizer, Inc., Abbott, GlaxoSmithKline plc, Sanofi S.A., Novartis AG, Bayer AG, Bristol Myers Squibb Company, Eli Lilly and Company, Inc., Accurate Surgical & Scientific Instruments Corporation, Sklar Surgical Instruments, Advanced Meditech International and others.

Segments

The global vasectomy market has been classified into type, drugs, end user, and patients,

On the basis of type, the market has been segmented as conventional vasectomy, no-scalpel vasectomy, and minimally invasive vasectomy.

Based on the drugs, the market has been segmented as anesthetics, painkillers, antibiotics, and others.

Based on the patients, the market has been segmented as human and animals.

Based on the end user, the market has been segmented as hospitals and clinics, research and academics, and others.

Read Comprehensive Overview of Report @ https://www.marketresearchfuture.com/reports/vasectomy-market-4703